Genetic epidemiology of infectious diseases in humans: Design of population-based studies

Emerging Infectious Diseases

Volumn 4, Issue 4, 1998, Pages 593-603

  Abel, Laurent ^a,c   Dessein, Alain J ^b  

^a Recherche Médicale Unit 436   (France)

^b Inst Natl de la Santé   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HUMAN; LEPROSY; MALARIA; POPULATION RESEARCH; REVIEW; SCHISTOSOMIASIS;

EID: 0031761192     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0404.980409     Document Type: Review

References (74)

1. Wakelin DM, Blackwell JM, editors. Genetics of resistance to bacterial and parasitic infection. London: Taylor and Francis; 1988.
2. McLeod R, Buschman E, Arbuckle LD, Skamene E. Immunogenetics in the analysis of resistance to intracellular pathogens. Curr Opin Immunol 1995;7:539-52.
3. Nadeau JH, Arbuckle LD, Skamene E. Genetic dissection of inflamatory responses. J Inflamm 1995;45:27-48.
4. Blackwell JM, Barton CH, White JK, Roach TIA, Shaw MA, Whitehead SH, et al. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunol Lett 1994;43:99-107.
5. Vidal S, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993;73:469-86.
6. Khoury MJ, Beaty TH, Cohen BH, editors. Fundamentals of Genetic Epidemiology. New York: Oxford University Press; 1993.
7. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-48.
8. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996;380:152-4.
9. Hill AVS. Genetics of infectious disease resistance. Curr Opin Genet Dev 1996;6:348-53.
10. Abel L, Dessein AJ. The impact of host genetics on susceptibility to human infectious diseases. Curr Opin Immunol 1997;509-16.
11. Bonney GE. Regressive logistic model for familial disease and other binary traits. Biometrics 1986;42:611-25.
12. Bonney GE. On the statistical determination of major gene mechanisms in continuous human traits: regressive models. Am J Med Genet 1984;18:731-49.
13. Morton NE. Sequential tests for the detection of linkage. Am J Hum Genet 1955;7:277-318.
14. Ott J, editor. Analysis of human genetic linkage. Baltimore and London: The Johns Hopkins University Press; 1991.
15. Clerget-Darpoux F, Bonaïti-Pellié C, Hochez J. Effects of mispecifying genetic parameters in lod-score analysis. Biometrics 1986;42:393-9.
16. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-7.
17. Abel L, Demenais F. Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade. Am J Hum Genet 1988;42:256-66.
18. Abel L, Lap VD, Oberti J, Thuc NV, Cua VV, Guilloud-Bataille M, et al. Complex segregation analysis of leprosy in Vietnam. Genet Epidemiol 1995;12:63-82.
19. Feitosa MF, Borecki I, Krieger H, Beiguelman B, Rao DC. The genetic epidemiology of leprosy in a Brazilian population. Am J Hum Genet 1995;56:1185-95.
20. Abel L, Demenais F, Baule MS, Blanc M, Muller A, Raffoux C, et al. Genetic susceptibility to leprosy on a Caribbean island: linkage analysis with five markers. International Journal of Leprosy 1989;57:465-71.
21. Abel L, Cot M, Mulder L, Carnevale P, Feingold J. Segregation analysis detects a major gene controlling blood infection levels in human malaria. Am J Hum Genet 1992;50:1308-17.
22. Garcia A, Cot M, Chippaux JP, Ranques S, Feingold J, Demenais F, et al. Genetic control of blood infection levels in human malaria: evidence for a complex genetic model. Am J Trop Med Hyg 1998;58:480-8.
23. Rihet P, Abel L, Traoré Y, Traoré-Leroux T, Aucan C, Fumoux F. Human malaria: segregation analysis of blood infection levels in a suburban area and a rural area in Burkina Faso. Genet Epidemiol 1998;15:435-50.
24. Dessein A, Abel L, Couissinier P, Demeure C, Rihet P, Kohlstaedt S, et al. Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni. Immunol Invest 1992;21:421-51.
25. Abel L, Demenais F, Prata A, Souza AE, Dessein A. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 1991;48:959-70.
26. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, Feingold J, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996;14:181-4.
27. Müller-Myhsok B, Stelma FF, Guissé-Sow F, Muntau B, Thye T, Burchard GD, et al. Further evidence suggesting the presence of a locus on human chromosome 5q31-q33 influencing the intensity of infection with Schistosoma mansoni. Am J Hum Genet 1997;61:452-4.
28. Marsh DG, Neely JD, Breazale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-6.
29. Meyers DA, Postma DS, Panhuysen CIM, Xu J, Amelung PJ, Levitt RC, et al. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 1994;23:464-70.
30. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CIM, et al. Genetic susceptibility to asthma - bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995;333:894-900.
31. Lin AY, Rioux JD, Nutman T, Daly M, Stone V, Nguyen H, et al. A gene for familial hypereosinophilia maps to chromosome 5q31-q33. Am J Hum Genet 1997;Suppl 61:A283.
32. Couissinier-Paris P, Dessein AJ. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur J Immunol 1995;25:2295-302.
33. Rodrigues V, Abel L, Piper K, Dessein AJ. Segregation analysis indicates a major gene in the control of interleukine-5 production in humans infected with Schistosoma mansoni. Am J Hum Genet 1996;59:453-61.
34. Risch N. Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am J Hum Genet 1990;46:242-53.
35. Abel L, Alcais A, Mallet A. Comparison of four sib-pair linkage methods for analyzing sibships with more than two affecteds: interest of the binomial maximum likelihood approach. Genet Epidemiol 1998;15:371-390.
36. Haseman JK, Elston RC. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet 1972;2:3-19.
37. Goldgar DE. Multipoint analysis of human quantitative genetic variation. Am J Hum Genet 1990;47:957-67.
38. Amos CI. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet 1994;54:535-43.
39. Blangero J, Almasy L. Multipoint oligogenic linkage analysis of quantitative traits. Genet Epidemiol 1997;14:959-64.
40. Kruglyak L, Lander ES. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet 1995;57:439-54.
41. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994;371:130-6.
42. Hashimoto L, Habita C, Beressi JP, Delepine M, Besse C, Cambon-Thomsen A, et al. Genetic mapping of a suceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994;371:161-4.
43. van Eden W, de Vries RRP. HLA and leprosy: a reevaluation. Lepr Rev 1984;55:89-104.
44. van Eden W, Gonzalez NM, de Vries RR, Convit J, Van Rood JJ. HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis 1985;151:9-14.
45. Ottenhoff TH, de Vries RR. HLA class II immune response and suppression genes in leprosy. International Journal of Leprosy 1987;55:521-34.
46. Cellier M, Govoni G, Vidal S, Groulx N, Liu J, Sanchez F, et al. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J Exp Med 1994;180:1741-52.
47. Abel L, Sanchez F, Oberti J, Thuc NV, Hoa LV, Lap VD, et al. Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis 1998;177:133-45.
48. Shaw MA, Atkinson S, Dockrell H, Hussain R, Lins-Lainson Z, Shaw J, et al. An RFLP map for 2q33-q37 from multicase mycobacterial and leishmanial disease families: no evidence for an Lsh/Ity/Bcg gene homologue influencing susceptibility to leprosy. Ann Hum Genet 1993;57:251-71.
49. Levee G, Liu J, Gicquel B, Chanteau S, Schurr E. Genetic control of susceptibility to leprosy in French Polynesia; no evidence for linkage with markers on telomeric human chromosome 2. International Journal of Leprosy 1994;62:499-511.
50. Jepson A, Sisay-Joof F, Banya W, Hassan-King M, Frodsham A, Bennett S, et al. Genetic linkage of mild malaria to the major histocompatibility complex in Gambian children: study of affected sibling pairs. BMJ 1997;315:96-7.
51. Garcia A, Marquet S, Bucheton B, Hillaire D, Cot M, Fievet N, et al. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 region. Am J Trop Med Hyg 1998;58:705-9.
52. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-9.
53. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, et al. Interferon-γ-receptor deficiency in an infant with fatal Bacille Calmette-Guérin infection. N Engl J Med 1996;335:1956-60.
54. Lander ES, Botstein D. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science 1987;236:1567-70.
55. Casanova JL, Newport M, Fisher A, Levin M. Inherited interferon gamma receptor deficiency. In: Ochs H, Puck J, Smith C, editors. Primary immunodeficiencies: a molecular and genetic approach. New York: Oxford University Press. In press 1998.
56. Schaid DJ, Sommer SS. Comparison of statistics for candidate-gene associations using cases and parents. Am J Hum Genet 1994;55:402-9.
57. Spielman RC, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-16.
58. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-7.
59. Müller-Myhsok B, Abel L. Genetic analysis of complex diseases. Science 1997;275:1328-9.
60. Zerva L, Cizman B, Mehra NK, Alahari SK, Murali R, Zmijewski CM, et al. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J Exp Med 1996;183:829-36.
61. Miller LH. Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc Natl Acad Sci U S A 1994;91:2415-9.
62. Ruwende C, Fhoo SC, Snow RW, Yates SNR, Kwiatkowski D, Gupta S, et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995;376:246-9.
63. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991;352;595-600.
64. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
65. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195-9.
66. Miller LH. Protective selective pressure. Nature 1996;383:480-1.
67. Fernandez-Reyes D, Craig AG, Kyes SA, Peshu N, Snow RW, Berendt AR, et al. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 1997;6:1357-60.
68. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
69. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
70. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996;382:722-5.
71. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-61.
72. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-3.
73. Michael NL, Chang G, Leslie GL, Mascola JR, Dondero D, Birx DL, et al. The role of viral phenotype and CCR5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997;3:338-40.
74. Martison JJ, Chapman NH, Rees DC, Liu YT, Clagg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nature Genet 1997;16:100-3.